
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT
- About


Nexgel Inc (NXGL)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/12/2025: NXGL (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $6
1 Year Target Price $6
0 | Strong Buy |
1 | Buy |
0 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -32.56% | Avg. Invested days 28 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 19.44M USD | Price to earnings Ratio - | 1Y Target Price 6 |
Price to earnings Ratio - | 1Y Target Price 6 | ||
Volume (30-day avg) 1 | Beta 0.58 | 52 Weeks Range 2.10 - 5.10 | Updated Date 09/14/2025 |
52 Weeks Range 2.10 - 5.10 | Updated Date 09/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.4 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -25.02% | Operating Margin (TTM) -22.05% |
Management Effectiveness
Return on Assets (TTM) -19.51% | Return on Equity (TTM) -60.47% |
Valuation
Trailing PE - | Forward PE 15.06 | Enterprise Value 21372867 | Price to Sales(TTM) 1.67 |
Enterprise Value 21372867 | Price to Sales(TTM) 1.67 | ||
Enterprise Value to Revenue 1.83 | Enterprise Value to EBITDA -0.85 | Shares Outstanding 8067580 | Shares Floating 6838323 |
Shares Outstanding 8067580 | Shares Floating 6838323 | ||
Percent Insiders 15.54 | Percent Institutions 8.94 |
Upturn AI SWOT
Nexgel Inc

Company Overview
History and Background
Nexgel, Inc. (NXGL) is an innovative advanced wound care company developing, manufacturing and distributing high water content hydrogels, primarily for advanced wound care and consumer skin care applications. Founded to deliver next-generation hydrogel technology, Nexgel is focused on developing innovative, cost-effective hydrogels with broad applicability.
Core Business Areas
- Advanced Wound Care: Nexgel develops and manufactures hydrogels used in dressings for chronic wounds, burns, and surgical incisions. These hydrogels promote healing by maintaining a moist environment and protecting the wound from infection.
- Consumer Skin Care: Nexgel offers hydrogels for consumer skincare applications, such as moisturizing masks and cooling patches. These products leverage the hydrating and soothing properties of hydrogels.
- Private Label & OEM: Nexgel manufactures hydrogels and converts them into finished goods for strategic partners on a private label and original equipment manufacturer (OEM) basis, in both the consumer and medical markets.
Leadership and Structure
Curtis G. Cluff is the CEO and a director. Organizational details beyond this are limited in publicly available sources.
Top Products and Market Share
Key Offerings
- Advanced Wound Care Dressings: Nexgel's hydrogel dressings are used in the treatment of chronic wounds, burns, and surgical incisions. Limited market share data is publicly available. Competitors include Smith & Nephew (SNN), Mu00f6lnlycke Health Care, and 3M (MMM).
- Consumer Skin Care Masks: Nexgel's hydrogel masks are marketed for moisturizing and soothing the skin. Limited market share data is publicly available. Competitors include Johnson & Johnson (JNJ) and L'Oru00e9al (OR).
- Private Label Hydrogel Products: Hydrogel products created for other companies. Exact numbers of customers/revenue not available.
Market Dynamics
Industry Overview
The advanced wound care market is driven by the increasing prevalence of chronic diseases like diabetes and obesity. The consumer skincare market is driven by aging populations and interest in skincare innovations. Hydrogel growth is due to its non-toxic properties, biocompatibility, and ability to create a moist wound healing environment.
Positioning
Nexgel positions itself as an innovator in hydrogel technology, offering cost-effective and versatile solutions for both medical and consumer applications. Their competitive advantage lies in their proprietary hydrogel formulation and manufacturing expertise. They aim to be a leader in hydrogel innovation.
Total Addressable Market (TAM)
The global advanced wound care market is estimated to reach tens of billions of dollars. The global cosmetic skin care market is estimated to reach hundreds of billions of dollars. Nexgel is positioned to capture a share of both of these markets with its innovative hydrogel technology, but the current market share is very small.
Upturn SWOT Analysis
Strengths
- Innovative hydrogel technology
- Cost-effective manufacturing
- Versatile applications (wound care, skincare)
- Private label and OEM opportunities
Weaknesses
- Limited brand recognition
- Small market share
- Reliance on partners for distribution
- Limited financial resources
Opportunities
- Expanding into new wound care applications
- Growing private label partnerships
- Increasing consumer awareness of hydrogel benefits
- Strategic acquisitions
Threats
- Competition from established players
- Regulatory hurdles
- Fluctuations in raw material costs
- Potential product liability claims
Competitors and Market Share
Key Competitors
- SNN
- MMM
- JNJ
Competitive Landscape
Nexgel faces stiff competition from established players with greater resources and brand recognition. Nexgel's advantages include its innovative hydrogel technology and cost-effective manufacturing, which allow it to compete on price and product performance. They are trying to improve on existing solutions by innovating on hydrogel technology.
Growth Trajectory and Initiatives
Historical Growth: Information unavailable without deeper data.
Future Projections: Future projections require analyst reviews.
Recent Initiatives: Nexgel's recent initiatives include expanding its private label partnerships and developing new hydrogel formulations for specific applications.
Summary
Nexgel is an innovative wound care company with promising hydrogel technology, but it faces challenges due to its small size and limited financial resources. The company's strengths lie in its cost-effective manufacturing and versatile applications, while its weaknesses include low brand recognition and reliance on partners. For Nexgel to become a significant player, it must improve its financial stability, brand awareness, and strategic position.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Industry Reports
- Market Research Reports
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market data is based on available information and may not be entirely accurate. Consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Nexgel Inc
Exchange NASDAQ | Headquaters Langhorne, PA, United States | ||
IPO Launch date 2021-12-22 | CEO, President & Director Mr. Adam R. Levy | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 19 | Website https://nexgel.com |
Full time employees 19 | Website https://nexgel.com |
NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also developing NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Lumagel Beauty, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.